Home/Filings/4/0000927066-24-000044
4//SEC Filing

STAFFIERI MICHAEL DAVID 4

Accession 0000927066-24-000044

CIK 0000927066other

Filed

Mar 17, 8:00 PM ET

Accepted

Mar 18, 7:14 PM ET

Size

10.6 KB

Accession

0000927066-24-000044

Insider Transaction Report

Form 4
Period: 2024-03-14
STAFFIERI MICHAEL DAVID
COO, Kidney Care
Transactions
  • Tax Payment

    Common Stock

    2024-03-15$136.00/sh12,008$1,633,08892,978 total
  • Award

    Common Stock

    2024-03-14+21,52489,647 total
  • Award

    Common Stock

    2024-03-14+2,16791,814 total
  • Award

    Common Stock

    2024-03-15+13,172104,986 total
Holdings
  • Common Stock

    (indirect: By Trust)
    158,506
Footnotes (4)
  • [F1]Shares received upon the satisfaction of performance criteria underlying the award of performance stock units granted to the Reporting Person on March 15, 2020, of which 100% vested on March 15, 2024.
  • [F2]Shares received upon the satisfaction of performance criteria underlying the award of performance stock units granted to the Reporting Person on March 15, 2021, of which 100% vested on March 15, 2024.
  • [F3]These restricted stock units are scheduled to vest 50% each on March 15, 2027 and March 15, 2028, subject to continued service through each applicable vesting date.
  • [F4]Shares withheld from issuance to satisfy tax withholding obligation in connection with the vesting of shares as described in footnotes 1 and 2 above.

Issuer

DAVITA INC.

CIK 0000927066

Entity typeother

Related Parties

1
  • filerCIK 0001604063

Filing Metadata

Form type
4
Filed
Mar 17, 8:00 PM ET
Accepted
Mar 18, 7:14 PM ET
Size
10.6 KB